FLK-1 + cells derived from mouse fetal liver could differentiate into endothelial cells and smooth muscle cells
10.3760/cma.j.issn.0253-3758.2010.12.013
- VernacularTitle:小鼠胎肝中胎肝激酶-1阳性细胞具有血管祖细胞的功能特性
- Author:
Cheng-Hao JIN
1
;
Yoshikazu YONEMITSU
;
Wei-Rong DING
;
Katsuo SUEISHI
Author Information
1. 江西省人民医院
- Keywords:
Vascular endothelial growth factor receptor-2;
Stem cell;
Cell differentiation;
Stem cell transplantation
- From:
Chinese Journal of Cardiology
2010;38(12):1108-1112
- CountryChina
- Language:Chinese
-
Abstract:
Objective To characterize the differential and proliferative activities of FLK-1+ cells derived from mouse fetal liver. Method The FLK-1+ fraction were enriched from the fetal liver using immunomagnetic method and their differential and proliferative activities were examined in culture medium and in vivo via transplantation of FLK-1 + cells into the inferior pole of the spleen of nine-week-old male C57BL/6 mice after two-thirds hepatectomy. Results In response to growth factors, FLK-1 + cells expressed typical lineage-specific markers for vascular endothelial cells, smooth muscle cells. Intrahepatic implantation of FLK-1 + cells resulted in the formation of blood vessels in the fibrous capsule of partially hepatectomized liver. Conclusion These results indicate that FLK-1 + cells derived from mouse fetal liver could differentiate into endothelial cells and smooth muscle cells and they may serve as potential stem cells for clinical cellbased therapy.